Related content

Serum Matrix-Metalloproteinase-1 is a Bona Fide Prognostic Marker for Colorectal Cancer

By Tahara Kouichirou  

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3362-3369

Springer Publishing Company

Access to resources Recommend Favorite

Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma

By Vuoristo M.-S.   Laine S.   Huhtala H.   Parvinen L.-M.   Hahka-Kemppinen M.   Korpela M.   Kumpulainen E.   Kellokumpu-Lehtinen P.  

European Journal of Cancer, Vol. 37, Iss. 13, 2001-09 ,pp. : 1629-1634

Elsevier

Access to resources Recommend Favorite

Progression of non-small cell lung cancer: Diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A

By Kanoh Yuhsaku   Abe Tadashi   Masuda Noriyuki   Akahoshi Tohru  

Oncology Reports, Vol. 29, Iss. 2, 2013-02 ,pp. : 469-473

Spandidos Publications

Access to resources Recommend Favorite

Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in patients with malignant melanoma

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Disci Rian   Kurul Sidika   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 22, Iss. 1, 2005-03 ,pp. : 39-44

Humana Press, Inc

Access to resources Recommend Favorite

Activated Matrix Metalloproteinase-2-A Potential Marker of Prognosis for Epithelial Ovarian Cancer

By Wu X.   Li H.   Kang L.   Li L.   Wang W.   Shan B.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 126-134

Elsevier

Access to resources Recommend Favorite